Stock listing
NSE:KPL Kwality Pharmaceuticals Ltd Share Price
Home listing (NSE) of Kwality Pharmaceuticals Ltd
Follow Kwality Pharmaceuticals Ltd into a list and get an email when it puts out news.
Share price · NSE:KPL
₹4,128.40 INR -79.50 (-1.9%)
Close on Nov 20, 2026
- Day range
- ₹4,106.50 – ₹4,282.00 INRNov 20, 2026
- Volume
- 43,610 sharesNov 20, 2026
- Market cap
- ₹42.84B INRAt the close on Nov 20, 2026 · price × 10.38M shares outstanding
- Traded on an average day
- ₹168.8M INRMedian day 32,635 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NSE:KPL · Home | ₹4,128.40 INR | -79.50 (-1.9%) | 43,610 | ₹4,227.80 | ₹4,282.00 | ₹4,106.50 | ₹4,207.90 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NSE:KPL · INR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₹4,128.40 | -79.50 | -1.9% | ₹4,227.80 | ₹4,282.00 | ₹4,106.50 | 43,610 | |
| ₹4,207.90 | +161.60 | +4.0% | ₹4,040.00 | ₹4,235.00 | ₹3,981.00 | 75,081 | |
| ₹4,046.30 | -2.10 | -0.1% | ₹4,007.00 | ₹4,085.00 | ₹3,980.00 | 40,667 | |
| ₹4,048.40 | +225.80 | +5.9% | ₹3,869.90 | ₹4,078.00 | ₹3,721.00 | 106,972 | |
| ₹3,822.60 | -126.10 | -3.2% | ₹3,960.00 | ₹4,100.00 | ₹3,783.10 | 95,001 | |
| ₹3,948.70 | -35.10 | -0.9% | ₹4,050.00 | ₹4,211.00 | ₹3,708.40 | 326,839 | |
| ₹3,983.80 | +127.40 | +3.3% | ₹3,899.90 | ₹4,066.20 | ₹3,780.50 | 101,595 | |
| ₹3,856.40 | +211.60 | +5.8% | ₹3,700.00 | ₹3,887.20 | ₹3,581.00 | 73,118 | |
| ₹3,644.80 | -42.50 | -1.2% | ₹3,699.50 | ₹3,724.20 | ₹3,553.10 | 20,631 | |
| ₹3,687.30 | -53.70 | -1.4% | ₹3,820.00 | ₹3,820.00 | ₹3,670.00 | 19,739 | |
| ₹3,741.00 | +110.10 | +3.0% | ₹3,679.00 | ₹3,783.00 | ₹3,583.10 | 36,031 | |
| ₹3,630.90 | +115.00 | +3.3% | ₹3,515.00 | ₹3,669.90 | ₹3,506.30 | 17,826 | |
| ₹3,515.90 | +40.60 | +1.2% | ₹3,450.00 | ₹3,566.30 | ₹3,401.00 | 14,597 | |
| ₹3,475.30 | -205.30 | -5.6% | ₹3,699.00 | ₹3,729.00 | ₹3,457.10 | 26,842 | |
| ₹3,680.60 | -16.10 | -0.4% | ₹3,678.30 | ₹3,711.90 | ₹3,601.10 | 19,011 | |
| ₹3,696.70 | +97.30 | +2.7% | ₹3,599.40 | ₹3,710.00 | ₹3,554.90 | 36,441 | |
| ₹3,599.40 | +137.70 | +4.0% | ₹3,511.00 | ₹3,625.00 | ₹3,511.00 | 20,524 | |
| ₹3,461.70 | -66.70 | -1.9% | ₹3,565.00 | ₹3,671.80 | ₹3,405.10 | 40,067 | |
| ₹3,528.40 | -89.90 | -2.5% | ₹3,571.00 | ₹3,605.00 | ₹3,433.10 | 38,711 | |
| ₹3,618.30 | +190.90 | +5.6% | ₹3,420.00 | ₹3,638.70 | ₹3,375.30 | 40,504 | |
| ₹3,427.40 | +61.40 | +1.8% | ₹3,428.00 | ₹3,475.90 | ₹3,315.30 | 42,901 | |
| ₹3,366.00 | -36.90 | -1.1% | ₹3,425.70 | ₹3,500.00 | ₹3,340.30 | 28,887 | |
| ₹3,402.90 | +87.00 | +2.6% | ₹3,354.70 | ₹3,448.80 | ₹3,325.00 | 23,012 | |
| ₹3,315.90 | -78.20 | -2.3% | ₹3,380.00 | ₹3,476.80 | ₹3,226.60 | 57,683 | |
| ₹3,394.10 | -139.20 | -3.9% | ₹3,529.70 | ₹3,530.00 | ₹3,362.20 | 24,339 | |
| ₹3,533.30 | -32.20 | -0.9% | ₹3,583.30 | ₹3,597.80 | ₹3,429.30 | 25,874 | |
| ₹3,565.50 | +1.20 | 0.0% | ₹3,599.00 | ₹3,620.80 | ₹3,540.20 | 13,272 | |
| ₹3,564.30 | +31.00 | +0.9% | ₹3,539.00 | ₹3,608.70 | ₹3,475.00 | 13,563 | |
| ₹3,533.30 | -147.90 | -4.0% | ₹3,680.00 | ₹3,680.00 | ₹3,511.50 | 27,259 | |
| ₹3,681.20 | -63.80 | -1.7% | ₹3,783.90 | ₹3,783.90 | ₹3,642.10 | 21,347 | |
| ₹3,745.00 | +100.80 | +2.8% | ₹3,644.20 | ₹3,777.00 | ₹3,580.50 | 29,281 | |
| ₹3,644.20 | +79.80 | +2.2% | ₹3,564.00 | ₹3,664.00 | ₹3,529.00 | 23,020 | |
| ₹3,564.40 | 0.00 | 0.0% | ₹3,564.40 | ₹3,564.40 | ₹3,564.40 | 0 | |
| ₹3,564.40 | -77.00 | -2.1% | ₹3,641.40 | ₹3,643.10 | ₹3,470.00 | 41,775 | |
| ₹3,641.40 | +16.30 | +0.4% | ₹3,699.00 | ₹3,699.00 | ₹3,611.10 | 14,030 | |
| ₹3,625.10 | +48.20 | +1.3% | ₹3,565.40 | ₹3,691.40 | ₹3,558.90 | 18,009 | |
| ₹3,576.90 | -95.40 | -2.6% | ₹3,672.30 | ₹3,730.00 | ₹3,556.80 | 29,057 | |
| ₹3,672.30 | +30.20 | +0.8% | ₹3,667.80 | ₹3,774.40 | ₹3,639.00 | 32,185 | |
| ₹3,642.10 | -82.40 | -2.2% | ₹3,743.00 | ₹3,777.40 | ₹3,602.00 | 34,399 | |
| ₹3,724.50 | -28.30 | -0.8% | ₹3,773.00 | ₹3,840.00 | ₹3,705.00 | 40,372 | |
| ₹3,752.80 | -92.10 | -2.4% | ₹3,819.90 | ₹3,819.90 | ₹3,682.00 | 58,050 | |
| ₹3,844.90 | +373.70 | +10.8% | ₹3,478.90 | ₹3,949.00 | ₹3,447.20 | 171,018 | |
| ₹3,471.20 | +19.10 | +0.6% | ₹3,471.20 | ₹3,564.90 | ₹3,430.10 | 28,652 | |
| ₹3,452.10 | +96.10 | +2.9% | ₹3,372.00 | ₹3,485.00 | ₹3,346.30 | 21,503 | |
| ₹3,356.00 | -74.60 | -2.2% | ₹3,420.10 | ₹3,477.20 | ₹3,137.00 | 82,018 | |
| ₹3,430.60 | -212.70 | -5.8% | ₹3,700.00 | ₹3,786.40 | ₹3,392.50 | 57,728 | |
| ₹3,643.30 | 0.00 | 0.0% | ₹3,643.30 | ₹3,643.30 | ₹3,643.30 | 0 | |
| ₹3,643.30 | +131.70 | +3.8% | ₹3,500.10 | ₹3,694.00 | ₹3,422.30 | 42,959 | |
| ₹3,511.60 | -65.40 | -1.8% | ₹3,619.90 | ₹3,619.90 | ₹3,464.00 | 18,178 | |
| ₹3,577.00 | -84.40 | -2.3% | ₹3,678.90 | ₹3,798.90 | ₹3,552.50 | 42,952 | |
| ₹3,661.40 | +250.20 | +7.3% | ₹3,443.00 | ₹3,710.00 | ₹3,442.90 | 162,467 | |
| ₹3,411.20 | +125.70 | +3.8% | ₹3,312.30 | ₹3,428.30 | ₹3,285.60 | 22,589 | |
| ₹3,285.50 | -66.20 | -2.0% | ₹3,350.00 | ₹3,421.70 | ₹3,211.10 | 49,245 | |
| ₹3,351.70 | -38.40 | -1.1% | ₹3,428.00 | ₹3,445.00 | ₹3,290.20 | 21,875 | |
| ₹3,390.10 | -0.40 | 0.0% | ₹3,388.90 | ₹3,425.00 | ₹3,324.10 | 25,588 | |
| ₹3,390.50 | +113.50 | +3.5% | ₹3,299.30 | ₹3,447.80 | ₹3,265.00 | 34,248 | |
| ₹3,277.00 | -37.30 | -1.1% | ₹3,337.00 | ₹3,337.00 | ₹3,230.10 | 16,351 | |
| ₹3,314.30 | +47.20 | +1.4% | ₹3,276.60 | ₹3,338.40 | ₹3,257.70 | 18,523 | |
| ₹3,267.10 | -59.00 | -1.8% | ₹3,324.90 | ₹3,418.80 | ₹3,250.00 | 26,045 | |
| ₹3,326.10 | -47.00 | -1.4% | ₹3,373.10 | ₹3,455.80 | ₹3,310.10 | 33,084 | |
| ₹3,373.10 | -79.10 | -2.3% | ₹3,465.90 | ₹3,529.80 | ₹3,350.00 | 45,124 | |
| ₹3,452.20 | +91.10 | +2.7% | ₹3,365.00 | ₹3,524.10 | ₹3,350.10 | 44,461 | |
| ₹3,361.10 | -269.20 | -7.4% | ₹3,604.10 | ₹3,634.50 | ₹3,327.00 | 113,735 | |
| ₹3,630.30 | +177.90 | +5.2% | ₹3,490.00 | ₹3,708.90 | ₹3,474.70 | 71,712 |
- Ticker
- NSE:KPL
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- NSE
- Currency
- INR
What changed lately
Latest news release · May 19, 2026
KPL: FY26 saw record revenue, margin expansion, and robust profit growth, with strong FY27 guidance
Latest news
Kwality Pharmaceuticals Ltd on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 1 in the last 12 months · 1 in all · newest May 19, 2026 · oldest 2026
Where Kwality Pharmaceuticals Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NSE:KPL · Home listing · This page | NSE | India | INR |
| BSE:KPL | BSE | India | INR |
Valuation
P/E 52.9× against a median of 38.0×: 6th lowest of 9 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · balance Mar 31, 2026 · price Nov 20, 2026
- Enterprise value
- ₹43.10B INR
- P/E
- 52.9×
- EV/sales
- 7.8×
- EV/EBITDA
- 31.9×
- Price/book
- 12.9×
- Gross margin
- 48.0%
- Operating margin
- 20.8%
- Net margin
- 14.6%
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Kwality Pharmaceuticals Ltd · NSE:KPL | US$462.3M | US$465.1M | 52.9× | 7.8× | 31.9× | 12.9× | 14.6% | 0.1× | n/a |
| Zhejiang Starry Pharmaceutical Co., Ltd. Class A · SSE:603520 | US$464.6M | US$595.8M | 116× | 1.5× | n/a | 1.3× | 1.0% | 0.5× | n/a |
| Ocumension Therapeutics · HKEX:1477 | US$464.3M | US$428.9M | n/a | 3.5× | n/a | 0.8× | −19.8% | 0.1× | n/a |
| Henan Taloph Pharmaceutical Stock Co. Ltd. Class A · SSE:600222 | US$464.3M | US$450.4M | 60.8× | 1.8× | n/a | 1.9× | 3.0% | 0.1× | n/a |
| Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A · SSE:600513 | US$462.7M | US$504.5M | n/a | n/a | n/a | 2.4× | n/a | 0.4× | n/a |
| Shandong Wohua Pharmaceutical Co., Ltd. Class A · SZSE:002107 | US$462.6M | US$404.6M | 26.0× | 3.4× | n/a | 4.4× | 15.1% | 0.0× | n/a |
| Fennec Pharmaceuticals Inc. · NASDAQ:FENC | US$462.1M | US$413.5M | 228× | 6.2× | 108× | 9.4× | 3.1% | 0.0× | 1.22 |
| Shandong Keyuan Pharmaceutical Co., Ltd. Class A · SZSE:301281 | US$460.6M | US$427.9M | 43.6× | 4.9× | n/a | 2.1× | 12.2% | 0.1× | n/a |
| YungShin Global Holding Corp. · TWSE:3705 | US$457.4M | US$406.9M | 16.8× | 1.7× | 9.4× | 1.9× | 11.4% | 0.2× | n/a |
| Hefei Lifeon Pharmaceutical Co., Ltd. Class A · SZSE:003020 | US$453.9M | US$379.1M | 19.7× | 1.7× | n/a | 1.6× | 10.5% | 0.1× | n/a |
| Newland Pharmaceutical Co., Ltd. Class A · SZSE:301277 | US$453.7M | US$354.2M | 32.5× | 3.2× | n/a | 2.0× | 12.7% | 0.0× | n/a |
| Median of the others | US$462.4M | US$420.7M | 38.0× | 3.2× | 58.8× | 1.9× | 10.5% | 0.1× | 1.22 |
Team and board
| Director | Role |
|---|---|
| Ramesh Arora | Chairman |
Financials
Annual, in INR
Income statement
| Line | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | 5.03B | 3.70B | 3.07B | 2.51B |
| Cost of revenue | 2.61B | 1.87B | 1.63B | 1.19B |
| Gross profit | 2.42B | 1.83B | 1.44B | 1.32B |
| Selling, general and administrative | 253.3M | 227.2M | 125.7M | 190.8M |
| Operating income | 984.5M | 621.0M | 467.9M | 457.7M |
| Depreciation and amortization | 198.1M | 182.9M | 195.6M | 149.6M |
| EBITDA | 1.18B | 803.9M | 663.5M | 607.3M |
| Interest expense | 109.7M | 98.8M | 103.9M | 60.2M |
| Income before tax | 894.9M | 541.4M | 311.0M | 255.7M |
| Net income | 673.5M | 398.5M | 238.0M | 193.7M |
| Earnings per share, basic | 64.90 | 38.40 | 22.93 | 18.67 |
Balance sheet
| Line | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Cash and equivalents | 7.36M | 120.2M | 22.6M | 30.7M |
| Short-term investments | 28.6M | 27.4M | 36.9M | 42.9M |
| Receivables | 2.80B | 1.54B | 1.14B | 716.9M |
| Inventory | 782.5M | 834.7M | 783.9M | 863.1M |
| Current assets | 4.06B | 2.84B | 2.43B | 2.07B |
| Total assets | 5.92B | 4.47B | 3.94B | 3.54B |
| Accounts payable | 1.02B | 557.9M | 443.2M | 351.9M |
| Current liabilities | 2.26B | 1.70B | 1.52B | 1.26B |
| Long-term debt | 294.0M | 151.2M | 195.6M | 273.0M |
| Total liabilities | 2.62B | 1.85B | 1.72B | 1.55B |
| Shareholders' equity | 3.32B | 2.64B | 2.24B | 2.01B |
| Shares outstanding | 10.4M | 10.4M | 10.4M | 10.4M |
Cash flow
| Line | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Cash from operations | 165.9M | 527.2M | 429.8M | 413.8M |
| Capital spending | -489.4M | -250.0M | -298.4M | -476.7M |
| Free cash flow | -323.5M | 277.2M | 131.4M | -62.9M |
| Change in cash | -112.8M | 97.6M | -8.12M | -60.6M |
Cap table
Built by 6ix from Kwality Pharmaceuticals Ltd’s releases
- Common shares
- 10,376,198
- Fully diluted
- 10,376,198
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 10,376,198 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 10,376,198 |
Log in to ask 6ix AI your own questions about Kwality Pharmaceuticals Ltd.